We are live on ! Find out more

IDEX

IEX

Market cap $17B

230.28 USD

-3.70

1.58%

At close Updated Aug 28, 4:00 PM EDT

Pre-market

After hours

230.28

0.00

0%

1 day

-1.58%

5 days

-1.76%

1 month

2.51%

3 months

9.64%

6 months

8.86%

Year to date

28.6%

1 year

39.38%

5 years

1.92%

10 years

142.25%

About: Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. The company generated $3.5 billion in revenue in 2025.

Employees: 8,700

Industrials Specialty Industrial Machinery

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 55%

Neutral 35%

Negative 10%

Zacks Investment Research

Why Is Idex (IEX) Up 0.1% Since Last Earnings Report?

Idex (IEX) reported earnings 30 days ago. What's next for the stock?

Why Is Idex (IEX) Up 0.1% Since Last Earnings Report?

Zacks Investment Research

Idex (IEX) Upgraded to Buy: Here's Why

Idex (IEX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Idex (IEX) Upgraded to Buy: Here's Why

Zacks Investment Research

Are You Looking for a Top Momentum Pick? Why Idex (IEX) is a Great Choice

Does Idex (IEX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Are You Looking for a Top Momentum Pick? Why Idex (IEX) is a Great Choice

IDEX Q2 Earnings Call Highlights

IDEX NYSE: IEX reported second-quarter 2026 results that exceeded its expectations, supported by growth in its Health & Science Technologies segment, stronger orders and operational execution. The company raised its full-year outlook for organic sales growth, adjusted EBITDA margin and adjusted earnings per share.

IDEX Q2 Earnings Call Highlights

IDEX Corporation (IEX) Q2 2026 Earnings Call Transcript

IDEX Corporation (IEX) Q2 2026 Earnings Call Transcript

IDEX Corporation (IEX) Q2 2026 Earnings Call Transcript

Zacks Investment Research

Compared to Estimates, Idex (IEX) Q2 Earnings: A Look at Key Metrics

The headline numbers for Idex (IEX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, Idex (IEX) Q2 Earnings: A Look at Key Metrics

Zacks Investment Research

Idex (IEX) Q2 Earnings and Revenues Top Estimates

Idex (IEX) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.1 per share. This compares to earnings of $2.07 per share a year ago.

Idex (IEX) Q2 Earnings and Revenues Top Estimates

IDEX Reports Second Quarter Results

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended June 30, 2026. “We are very pleased to see continued results momentum as our IDEX teams drove another quarter of strong sales and earnings growth. Orders of over $1 billion in the quarter were a record as we continue to see elevated demand across the advantaged markets where we've focused our investments and capabilities,” said Eric D. Ashleman, IDEX Corporation.

IDEX Reports Second Quarter Results

Zacks Investment Research

IDEX Gears Up to Report Q2 Earnings: What's in the Cards?

IEX reports Q2 results on July 29, with revenue growth expected as Health & Science demand and acquisitions support sales despite cost pressures.

IDEX Gears Up to Report Q2 Earnings: What's in the Cards?

Zacks Investment Research

Idex (IEX) Earnings Expected to Grow: Should You Buy?

Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Idex (IEX) Earnings Expected to Grow: Should You Buy?

See News Rankings

Price charts implemented using Lightweight Charts™